ArticleFrontiers in pharmacology2025

Homotherapy for heteropathy of chronic kidney disease and oligoasthenozoospermia through regulating SIRT1/NF-κB pathway by Shenqi pills.

Shuo Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.